Instadose Pharma Corp. (INSD)

USD 0.0

(0.0%)

EBITDA Summary of Instadose Pharma Corp.

Instadose Pharma Corp.'s latest annual EBITDA in 2023 was - USD , up 100.0% from previous year.
Instadose Pharma Corp.'s latest quarterly EBITDA in 2024 Q1 was - USD , down 0.0% from previous quarter.
Instadose Pharma Corp. reported an annual EBITDA of - USD in 2022, down -1667.18% from previous year.
Instadose Pharma Corp. reported an annual EBITDA of - USD in 2021, down -7.72% from previous year.
Instadose Pharma Corp. reported a quarterly EBITDA of - USD for 2023 Q3, down 0.0% from previous quarter.
Instadose Pharma Corp. reported a quarterly EBITDA of N/A for 2023 FY, up 100.0% from previous quarter.

Annual EBITDA Chart of Instadose Pharma Corp. (2023 - 2017)

Historical Annual EBITDA of Instadose Pharma Corp. (2023 - 2017)

Year	EBITDA	EBITDA Growth
2023	- USD	100.0%
2022	- USD	-1667.18%
2021	- USD	-7.72%
2020	-23.27 Thousand USD	1.05%
2019	-31.25 Thousand USD	23.98%
2018	-31.94 Thousand USD	-2019.21%
2017	-1940.00 USD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	- USD	0.0%
2023 Q3	- USD	0.0%
2023 FY	- USD	100.0%
2023 Q4	- USD	0.0%
2023 Q1	- USD	0.0%
2023 Q2	- USD	0.0%
2022 FY	- USD	-1667.18%
2022 Q3	-615.38 Thousand USD	-37.9%
2022 Q2	-446.25 Thousand USD	-569.77%
2022 Q1	-66.62 Thousand USD	-15.0%
2021 Q3	-15.5 Thousand USD	-49.7%
2021 Q1	-5355.89 USD	18.91%
2021 Q4	-57.93 Thousand USD	-273.63%
2021 Q2	-10.35 Thousand USD	-93.4%
2021 FY	- USD	-7.72%
2020 FY	- USD	1.05%
2020 Q4	-6605.23 USD	44.25%
2020 Q3	-11.84 Thousand USD	-105.05%
2020 Q2	-5778.15 USD	13.38%
2020 Q1	-6670.52 USD	-6.46%
2019 Q3	-12.08 Thousand USD	-135.41%
2019 Q2	-5135.01 USD	-2.03%
2019 Q1	-5032.66 USD	22.0%
2019 FY	- USD	23.98%
2019 Q4	-6265.74 USD	48.17%
2018 Q3	-14.34 Thousand USD	32.99%
2018 Q1	-4897.76 USD	-33.66%
2018 Q4	-6452.51 USD	55.03%
2018 Q2	-21.41 Thousand USD	-337.23%
2018 FY	- USD	-2019.21%
2017 Q2	-2607.81 USD	0.0%
2017 Q3	-11.87 Thousand USD	-355.49%
2017 FY	- USD	0.0%
2017 Q4	-3664.33 USD	69.15%

Peer EBITDA Comparison of Instadose Pharma Corp.

Name	EBITDA	EBITDA Difference
BioQuest Corp.	-33.57 USD	100.0%
GSRX Industries Inc.	- USD	NaN%
High Sierra Technologies, Inc.	-181.97 Thousand USD	100.0%